Swaziland

You are here:-Swaziland
Swaziland2018-11-11T12:25:32+00:00

Background

Swaziland is classified by WHO as a high burden HIV country – 73% of TB patients were HIV positive in 2014.  While uptake of CPT among TB/HIV co-infected patients was high (98%), only 79% of HIV-positive TB patients were on ART.

Scaling-Up Coordinated TB/HIV Treatment

In 2012, the TB CARE II project, including URC and its partners Jhpiego and the Global TB Institute (GTBI) undertook a multi-country assessment aimed at identifying some of the programmatic factors that have contributed to success in increasing the numbers of co-infected TB patients accessing ART in a timely manner. The countries selected—South Africa, Swaziland, and Zimbabwe—have developed different models for delivering TB and HIV treatment and provide important lessons to guide the further scale-up coordinated TB and HIV treatment. The assessments focused at the service delivery level in sites with evident success in order to elucidate the service delivery models used and the best field practices developed around TB/HIV integration and early initiation of ART. The lessons and practices described in each country assessment have been combined to develop a practical framework to support the implementation of service delivery interventions geared at increasing early initiation of ART for TB patients.

Addressing Delays in TB Diagnosis

Effective TB control programs require early diagnosis and immediate initiation into treatment to reduce transmission.  In 2011, the USAID funded TB CARE II Project developed a framework for analyzing TB delay along with a set of tools to collect data on patient delays. TB CARE II then conducted field assessments using these tools in two high-burden TB countries— Bangladesh and Swaziland—in order to identify specific factors causing delay.  The project has compiled the knowledge gained from these field assessments into a Toolkit to Address Timely TB Case Detection and Treatment.  The purpose of this toolkit is to provide local TB and health program managers step-by-step assistance in understanding and identifying the possible reasons why people with TB symptoms delay in getting diagnosed and treated for TB.  Additionally, the toolkit provides guidance on interventions to address these delays, emphasizing the importance of utilizing a patient-centered approach to care. Click here to access the toolkit.

News Related to TB and Swaziland

REDUCING TB DELAYS: EVALUATING THE FREQUENCY AND CAUSES OF DELAYS IN BANGLADESH AND SWAZILAND

In 2011-2012, TB CARE II undertook a study to understand TB patients’ delays and inform the development of an integrated set of recommendations for TB program managers and service providers regarding the appropriateness of different strategies for reducing patient factor delays in accessing TB diagnostic and treatment services. The project, led by URC, developed a series of questionnaires which were field tested and applied to conduct field studies in

TB CARE II INTRODUCES TOOLKIT TO ADDRESS TIMELY TB CASE DETECTION AND TREATMENT

An effective tuberculosis (TB) control program requires early diagnosis and immediate initiation into treatment to reduce transmission.  In 2011, recognizing this fact, the USAID funded TB CARE II Project developed a framework for analyzing TB delay along with a set of tools to collect data on patient delays. TB CARE II then conducted field assessments using these tools in two high-burden TB countries— Bangladesh and Swaziland—in order to identify specific

Isoniazid Preventative Therapy (IPT) in Swaziland

Isoniazid Preventative Therapy (IPT) is a highly effective tuberculosis (TB) prevention method for people living with HIV, with a 33-64% reduction in TB in HIV+ patients who completed IPT. This benefit is enhanced to an 80-95% reduction when IPT is combined with proper anti-retroviral therapy (ART). Despite this clear and tangible benefit, global uptake of IPT has been low with only 10% of eligible patients initiated on IPT, and

URC Participation at the 48th Annual Union World Conference on Lung Health

The Union World Conference on Lung Health continues to be the largest gathering of clinicians and public health professionals, program managers, policymakers, researchers, and advocates working to end the suffering caused by TB and other lung diseases. The 48th annual conference, held in Guadalajara, Mexico on October 11-14, 2017, continued this tradition with fruitful discussions, research presentations, and other cutting-edge developments. This year’s theme – Accelerating Toward Elimination –